<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4477">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657809</url>
  </required_header>
  <id_info>
    <org_study_id>S85insu23fdf</org_study_id>
    <nct_id>NCT04657809</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia</brief_title>
  <official_title>&quot;Insulin Fast Dissolving Film for Intranasal Delivery Via Olfactory Region, a Promising Approach for the Treatment of Anosmia in COVID 19 Patients: Design, In-vitro Characterization and Clinical Evaluation.&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soad Ali</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Deraya University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to investigate the efficacy of insulin in a new dosage form ( fast dissolving&#xD;
      film) in treatment of anosmia in patients post infested with Covid-19. The study implication&#xD;
      based in two methods evaluations&#xD;
&#xD;
        1. Threshold test&#xD;
&#xD;
        2. identification test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed to improve smell disorders after corona infection that is very&#xD;
      anxious for all patients.&#xD;
&#xD;
      Inclusion criteria were loss of smell, post covid-19 infection, age from 18 to 70 years and&#xD;
      accept sharing and follow up.&#xD;
&#xD;
      The application of dosage form by ENT specialist at otorhinolaryngology clinic at Minia&#xD;
      University hospital. Dose was 100iu of insulin 3 times weekly for 4 weeks. The new dosage&#xD;
      form with insulin was compared with a placebo to ensure statistical improvement.&#xD;
&#xD;
      The tests were performed in each visit. Primary outcome was the improvement of smell sensors&#xD;
      in those patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smell sensation improvement</measure>
    <time_frame>4 weeks</time_frame>
    <description>By decrease the threshold sensation with butanol test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anosmia</condition>
  <arm_group>
    <arm_group_label>Insulin fast dissolving film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formulated bioadhesive fast dissolving film contains 100IU of insulin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plain fast dissolving film</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Formulated bioadhesive fast dissolving film contains no drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Insulin film</intervention_name>
    <description>Insulin suspension vials</description>
    <arm_group_label>Insulin fast dissolving film</arm_group_label>
    <arm_group_label>Plain fast dissolving film</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fast dissolving film</intervention_name>
    <description>Fast dissolving film</description>
    <arm_group_label>Insulin fast dissolving film</arm_group_label>
    <arm_group_label>Plain fast dissolving film</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  anosmia post covid-19 infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  nasal polyps or fractions or syrgery in nose from 6 months or less&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soad Mohamed</last_name>
    <role>Study Director</role>
    <affiliation>Deraya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Soad</name>
      <address>
        <city>Minya</city>
        <zip>05637</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 2, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Deraya University</investigator_affiliation>
    <investigator_full_name>Soad Ali</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olfaction Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

